Publication: Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure
Loading...
Files
Program
relationships.isAuthorOf
Author
DEMİR, MESUT
KANADAŞI, MEHMET
BACAKSIZ, AHMET
Vatankulu, Mehmet Akif
Sahin, Durmus Yildiray
Eker, Rabia Akilli
BOZKURT, ABDİ
Acarturk, Esmeray
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Background: Levosimendan (LS) is a novel inodilator that improves cardiac performance, central hemodynamics, and symptoms of patients with decompensated chronic heart failure. The aim of this study was to compare the effects of single and repeated LS infusion on left ventricular performance, biomarkers, and neurohormonal activation in patients with acute heart failure.
Description
Source
Keywords
Keywords
Citation
Tasal A., DEMİR M., KANADAŞI M., BACAKSIZ A., Vatankulu M. A. , Sahin D. Y. , Eker R. A. , BOZKURT A., Acarturk E., -Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure-, MEDICAL SCIENCE MONITOR, cilt.20, 2014